Effect of Combination tablets with telmisartan and amlodipine in hypertensive patients with metabolic syndrome not controlled by conventional therapy, randomized, open label, multicenter, parallel group study
Not Applicable
- Conditions
- Hypertension with metabolic syndrome
- Registration Number
- JPRN-UMIN000005265
- Lead Sponsor
- Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) Secondary hypertension 2) Severe hypertension with office systolic blood pressure over 180mmHg and/or diastolic blood pressure over 110mmHg 3) Malignant hypertension 4) Continuous ventricular tachycardia or severe arrythmia (AV block II-III, Af etc) 5) Severe heart failure (NYHA III-IV) 6) Myocardial Infarction, Coronary bypass surgery, and PTCA were performed within 6 months 7) Patients contraindicated for the use of amlodipine, telmisartan 8) Serum creatinine >2.1mg/dL 9) Hypersensitivity with telmisartan and amlodipine 10) Patients who are inadequate to entry this study judged by physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method